A retrospective study assessing the prevalence and factors influencing EM R/P in ALL following BLINA therapy
Latest Information Update: 18 Oct 2021
At a glance
- Drugs Blinatumomab (Primary)
- Indications Precursor B-cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 11 Oct 2021 Results published in the Cancer
- 02 Aug 2021 New trial record
- 17 Jun 2021 Results presented at the 26th Congress of the European Haematology Association